Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Breast Neoplasms 13Neoplasms 12Brain Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Sarcoma 3Multiple Myeloma 3Melanoma 3Glioblastoma 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2Rectal Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroendocrine Tumors 2Nasopharyngeal Carcinoma 2Mesothelioma 2Liposarcoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Glioma 2Fatigue 2Colorectal Neoplasms 2

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 15pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Quality of Life × Clear all
NCT03257618 2026-03-12

TEMOIN

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
26 enrolled
CNS

Glioma

NCT00667394 2015-11-05

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled 11 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡